Anti-S100A8 & S100A9 [5.5] mAb
Exclusive ToolExpression is lost on tissue maturation of monocytes to macrophages. S100A9 may be associated with monocyte and neutrophil activation and the accumulation of these cells in inflammatory sites.
Contributors
| Inventor | Institute |
|---|---|
| Nancy Hogg | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151056 |
|---|---|
| Product description: | S100A8 (MRP-8) and S100A9 (MRP-14) are cytosolic calcium-binding proteins of 8kDa and 14kDa that form a heterodimer. S100A8 and S100A9 are expressed in secretory and inflamed keratinocytes, peripheral blood monocytes, neutrophils and has been described in platelets, dendritic cells and some T cell types. Expression is lost on tissue maturation of monocytes to macrophages. S100A9 may be associated with monocyte and neutrophil activation and the accumulation of these cells in inflammatory sites. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 37 kDa |
| Immunogen: | Acute monocytic leukaemia cells. |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 151056 |
|---|---|
| Provenance and Ownership: | The Anti-S100A8 & S100A9 5.5 mAb is owned by Cancer Research UK. CancerTools supplies the Anti-S100A8 & S100A9 5.5 mAb under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-S100A8 & S100A9 5.5 mAb directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology; Genetics |
| Application: | ELISA ; FACS ; IHC ; IP ; WB |
| Target: | S100A8 (MRP-8) & S100A9 (MRP-14) |
| Reactivity: | Human |
| Clone: | 5.5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | S100A8 (MRP-8) and S100A9 (MRP-14) are cytosolic calcium-binding proteins of 8kDa and 14kDa that form a heterodimer. S100A8 and S100A9 are expressed in secretory and inflamed keratinocytes, peripheral blood monocytes, neutrophils and has been described in platelets, dendritic cells and some T cell types. Expression is lost on tissue maturation of monocytes to macrophages. S100A9 may be associated with monocyte and neutrophil activation and the accumulation of these cells in inflammatory sites. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Wen et al. 2018. Nat Med. 24(2):154-164. PMID: 29291352. Wang et al. 2014. J Clin Invest. 124(5):2160-71. PMID: 24691441. Ryckman et al. 2003. Arthritis Rheum. 48(8):2310-20. PMID: 12905486. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Hessian et al. 2001. Eur J Biochem. 268(2):353-63. PMID: 11168370. Hessian et al. 2001. Eur J Biochem. 268(2):353-63. PMID: 11168370. The heterodimeric complex of MRP-8 (S100A8) and MRP-14 (S100A9). Antibody recognition, epitope definition and the implications for structure. Edgeworth et al. 1991. J Biol Chem. 266(12):7706-13. PMID: 2019594. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. Hogg et al. 1989. Eur J Immunol. 19(6):1053-61. PMID: 2666142. Hogg et al. 1989. Eur J Immunol. 19(6):1053-61. PMID: 2666142. Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium. |
|---|
Images
View Gallery
Product Images
70969ef2-5ebf-4735-b66f-af5baa6bba6c.jpg
Adapted from Hessian PA; Fisher L. The heterodimeric complex of MRP-8 (S100A8) and MRP-14 (S100A9). Antibody recognition; epitope definition and the implications for structure. Eur J Biochem. 2001 Jan;268(2)
